Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Toremifene and Advances in Endocrine Breast Cancer Therapy
2026-06-26
The reviewed paper synthesizes 20 years of clinical data on toremifene, a selective estrogen receptor modulator (SERM), highlighting its efficacy and safety in hormone-sensitive breast cancer management. This work illuminates how biomarker-driven, personalized endocrine therapy—complemented by mechanistically distinct agents such as steroidal aromatase inhibitors—continues to refine treatment precision for breast cancer.
-
Isorhamnetin in Cell Signaling: Expanding Beyond Oocyte Matu
2026-06-26
Discover how Isorhamnetin, a naturally occurring flavonoid, modulates MAPK and PI3K/Akt pathways for advanced cell signaling studies. Uniquely, this article delves into cross-application insights and protocol optimization for apoptosis and oxidative stress assays.
-
O-propargyl-puromycin (OPP): Precision Protein Synthesis Det
2026-06-25
O-propargyl-puromycin (OPP) enables high-resolution, quantitative measurement of nascent protein synthesis in living cells, unlocking advanced workflows in immunology and proteomics. Recent studies translate mitochondrial regulation into practical assay choices, allowing researchers to dissect B cell function and antibody production with unprecedented sensitivity.
-
Amyloid Beta-Peptide (1-40) (human): Advanced Workflows & In
2026-06-25
Amyloid Beta-Peptide (1-40) (human) from APExBIO delivers translational power for Alzheimer’s disease research, now reinforced by groundbreaking evidence of its regulatory role in microglial activity. Explore optimized protocols, troubleshooting tactics, and new experimental directions that set this peptide apart as a gold-standard in neurodegeneration studies.
-
PP 1: Precision Src Family Tyrosine Kinase Inhibitor Protoco
2026-06-24
PP 1 delivers nanomolar potency and remarkable selectivity for dissecting Src-family kinase signaling in cancer and immune modulation studies. This guide translates cutting-edge reference findings and bench workflows into actionable protocols, troubleshooting, and advanced applications for researchers seeking robust inhibition of Src family kinases.
-
Hydroxytyrosol (SKU N2302): Reliable Antioxidant for Cell As
2026-06-23
This scenario-driven article equips biomedical researchers and lab technicians with evidence-based strategies for integrating Hydroxytyrosol (SKU N2302) into cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed data and product-specific parameters, it demonstrates how APExBIO’s high-purity Hydroxytyrosol ensures reproducibility, assay sensitivity, and workflow compatibility in oxidative stress and inflammation models.
-
Biotin-16-UTP: Precision RNA Labeling for Live-Cell Protein
2026-06-23
Explore how Biotin-16-UTP enables high-fidelity, biotin-labeled uridine triphosphate incorporation for advanced RNA detection and purification. This article uniquely focuses on live-cell protein tracking and assay design, offering new scientific insights and practical protocol guidance.
-
ECL Chemiluminescent Substrate Detection Kit: Sensitive Work
2026-06-22
The ECL Chemiluminescent Substrate Detection Kit enables ultrasensitive, reproducible HRP-based detection in Western blot and chemiluminescent immunoassays. Explore applied workflows, optimization strategies, and troubleshooting tips that empower research on complex signaling pathways.
-
Biotin-16-UTP: Practical Guide for RNA Labeling Protocols
2026-06-22
Biotin-16-UTP addresses the need for robust, non-radioactive labeling of RNA during in vitro transcription, facilitating sensitive RNA detection and purification workflows. It is not recommended for diagnostic or therapeutic applications, and users should be aware of its storage and stability limitations.
-
AhR-RBX1-HSF1 Pathway Modulates Tight Junctions in Pancreati
2026-06-21
Fang et al. characterize a novel regulatory axis in acute pancreatitis, demonstrating how aryl hydrocarbon receptor (AhR) activation preserves pancreatic tight junction integrity via the RBX1/HSF1 pathway. This mechanistic insight opens new avenues for targeting inflammatory and epithelial barrier disruptions in gastrointestinal disease.
-
Ionomycin Calcium Salt: Optimized Workflows for Cancer Signa
2026-06-20
Ionomycin calcium salt from APExBIO empowers precise manipulation of intracellular Ca2+ for advanced cancer signaling and apoptosis studies. This article provides detailed experimental workflows, troubleshooting strategies, and direct protocol enhancements that set this calcium ionophore apart in translational research.
-
GSK343: Selective EZH2 Inhibitor for Epigenetic Cancer Resea
2026-06-19
GSK343 is a potent, cell-permeable EZH2 inhibitor that enables precise inhibition of histone H3K27 trimethylation in cancer models. Its high selectivity and well-characterized activity profile make it a critical tool for epigenetic cancer research and functional genomics.
-
Cefiderocol Activity in Resistant P. aeruginosa and Acinetob
2026-06-19
The reference study establishes that cefiderocol maintains potent in vitro activity against European Pseudomonas aeruginosa and Acinetobacter spp., including strains resistant to meropenem and advanced β-lactam/β-lactamase inhibitor combinations. These findings inform the selection of effective therapies for multidrug-resistant Gram-negative infections and underscore the value of comprehensive susceptibility testing.
-
Reversine Protocol Guidance: Aurora Kinase Inhibition in Can
2026-06-18
Reversine is a targeted Aurora kinase inhibitor designed for precise modulation of mitotic events in cancer biology workflows. It supports researchers investigating cell cycle regulation, checkpoint control, and apoptosis induction in cancer cells. This reagent is not intended for diagnostic or clinical applications and should be used strictly in research settings.
-
SD 169 (indole-5-carboxamide): Applied p38 MAPK Inhibition
2026-06-18
SD 169 (indole-5-carboxamide) enables precision inhibition of the p38α/β MAPK pathway for advanced diabetes, neuroregeneration, and cell signaling research. Its dual-action mechanism and high selectivity empower researchers to achieve reproducible results and unlock new experimental dimensions, as revealed by recent structural breakthroughs.